Showing results (1601-1610 of 1,920) with videos related to
Sort By:
Pageof 192
RMD Open|November 10, 2025
Optical coherence tomography angiography detects retinal microvascular changes in giant cell arteritis: the potential protective role of aortitisSimon M Petzinna, Leon von der Emde, Julia Esser, et al.RMD Open|October 30, 2025
Joint involvement in VEXAS and non-VEXAS clonal haematopoiesis: two clusters from a multicentre regional cohortBaptiste de Maleprade, Fabien Jastrzebski, Ygal Benhamou, et al.RMD Open|October 30, 2025
Evaluation of spondyloarthritis-specific health utility based on ASAS health index (U-ASAS-HI) among the disease subtypes: an ancillary analysis from the ASAS-PerSpA studyOmar-Javier Calixto, Xenofon Baraliakos, Wilson Bautista-Molano, et al.RMD Open|September 24, 2025
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive proteinAlla Ishchenko, Margot Van Mechelen, Sofia Pazmino, et al.RMD Open|August 13, 2025
Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudyKevin L Winthrop, Justin Klaff, Sara K Penn, et al.RMD Open|September 22, 2025
Assessment of the minimal clinically important difference for the Health Assessment Questionnaire Disability Index in patients with arthralgia at risk for progression to rheumatoid arthritisStijn Claassen, Hanna W van Steenbergen, Annette H M van der Helm-van MilRMD Open|October 16, 2025
Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosisKatherine E van der Wouden, Saad Ahmed, Wieke M van Oostveen, et al.RMD Open|October 17, 2025
Utility of repeat MRI in assessing treatment non-response in axial spondyloarthritis: data from two large tertiary rheumatology centresJake Weddell, Ayaan Farah, Rahul Shah, et al.RMD Open|August 4, 2025
Deciphering differential biomarkers for anti-interleukin-6 receptor and anti-tumour necrosis factor-α treatment response in rheumatoid arthritis by multiomics analysisInoncent Agueusop, Daniel Margerie, Anne Remaury, et al.RMD Open|August 8, 2025
Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNAYuta Yamashita, Yasuhiko Yamano, Yoshinao Muro, et al.Pageof 192